Noncanonical NF-kappaB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation

Blood. 2007 Sep 1;110(5):1540-9. doi: 10.1182/blood-2006-11-056010. Epub 2007 May 4.

Abstract

Ligation of CD40 on dendritic cells (DCs) induces early production of inflammatory mediators via canonical NF-kappaB signaling, as well as late expression of the anti-inflammatory enzyme indoleamine 2,3-dioxygenase (IDO) via unknown signal transduction. By selective blocking of either the canonical NF-kappaB pathway using the NEMO-binding domain peptide or the noncanonical NF-kappaB pathway by small interfering RNA, we demonstrate that IDO expression requires noncanonical NF-kappaB signaling. Also, noncanonical NF-kappaB signaling down-regulates proinflammatory cytokine production in DCs. In addition, selective activation of the noncanonical NF-kappaB pathway results in noninflammatory DCs that suppress T-cell activation and promote the development of T cells with regulatory properties. These findings reveal an important role of the noncanonical NF-kappaB pathway in the regulation of immunity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Cytokines / biosynthesis
  • Cytokines / immunology
  • Dendritic Cells / enzymology
  • Dendritic Cells / immunology*
  • Gene Expression Regulation, Enzymologic / drug effects
  • Gene Expression Regulation, Enzymologic / immunology*
  • Humans
  • I-kappa B Kinase / immunology
  • I-kappa B Kinase / metabolism
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / biosynthesis
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / immunology*
  • Inflammation / immunology
  • Inflammation / metabolism
  • Lymphocyte Activation / drug effects
  • Lymphocyte Activation / immunology*
  • Mice
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / immunology*
  • NF-kappa B / metabolism
  • Peptides / immunology
  • Peptides / metabolism
  • Peptides / pharmacology
  • Protein Binding / drug effects
  • Protein Binding / immunology
  • RNA, Small Interfering / immunology
  • RNA, Small Interfering / pharmacology
  • Signal Transduction / drug effects
  • Signal Transduction / immunology*
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism

Substances

  • Cytokines
  • IKBKG protein, human
  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • NF-kappa B
  • Peptides
  • RNA, Small Interfering
  • I-kappa B Kinase